Bovipast Bovipast RSP

Product Information for Public -

An aqueous suspension for subcutaneous injection. One dose (5 ml) of the vaccine contains at least 10^5.5 TCID₅₀ inactivated Bovine Respiratory Syncytial virus (strain EV 908) and at least 10^7.3 TCID₅₀ Parainfluenza-3- virus (strain SF-4 Reisinger), together with 9 x 10⁹ cells inactivated Mannheimia (Pasteurella) haemolytica bacteria (serotype A1) propagated under conditions of iron restriction. Aluminium hydroxide and Quil A are included as adjuvants. Sodium timerfonate is included as a preservative.

For the active immunisation of cattle against
- Parainfluenza3 virus (PI3 virus), to reduce infections.
- Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs.
- Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6.

Legal category
POM-V

Packaging Quantities
50 ml bottle (10 doses)